Merck & Co. stock after-hours at EUR 127.25: minus 0.45 percent versus prior close
Published on 10/02/2026 at 18:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Merck & Co. stock was at EUR 127.25 in after-hours trading at 6:18 p.m. CEST on October 2, 2026. That was minus 0.45 percent versus the EUR 127.83 prior close at Lang & Schwarz on October 1, 2026. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Merck & Co. stock.
Positive Phase 2b data for tulisokibart
In a September 30, 2026 release, Merck said its Phase 2b MK-7240-012 study met its primary endpoint in patients with moderate to severe hidradenitis suppurativa. HiSCR50 was achieved by 72 percent of patients in the high-dose group and 64 percent in the medium-dose group, compared with 35 percent for placebo. Merck said it plans to advance tulisokibart into Phase 3 development for the condition.
Third-quarter call scheduled for October 29
Merck said in a release dated October 1, 2026, that it will hold its third-quarter 2026 sales and earnings conference call on October 29, 2026, at 9:00 a.m. ET. Company executives are scheduled to provide an overview of the quarter, according to Merck.
